Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori
Helicobacter · 2023
DOI: 10.1111/hel.12974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helicobacter, 2023. Verfasst von Young-Min Kwon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Hallym University Research Fund.
Abstract (Originalsprache)
Background
Macrolide antibiotics are widely used to treat various infections such as pneumonia and sinusitis, and previous exposure to macrolides is presumed to be a risk factor for standard triple therapy failure in Helicobacter pylori (H. pylori) eradication. We aimed to determine whether previous use of macrolide antibiotics could affect clarithromycin resistance of H. pylori . Materials and methods From the Korea National Health Insurance Service (NHIS2021‐1‐775) database, a total of 46,160 patients who were tested for clarithromycin resistance of H. pylori from 2016 to 2019 in Korea were identified. Their history of antibiotics in the past 10 years and history of respiratory comorbidity in the past 1 year were investigated.
Results
Clarithromycin resistance rate of H. pylori in Korea was 16.2%. A multivariate analysis revealed that female sex (OR: 1.472, p < .001), age > 50 years (OR: 1.340, p < .001), previous use of macrolide antibiotics (clarithromycin, OR: 2.902, p < .001; azithromycin, OR: 1.930, p < .001; erythromycin, OR: 2.060, p = .001; roxithromycin, OR: 2.022, p < .001), and history of respiratory comorbidity (sinusitis, OR: 1.271, p < .001; laryngopharyngitis, OR: 1.135, p = .032; bronchitis, OR: 1.245, p = .001; pneumonia, OR: 1.335, p = .026) were independent risk factors of clarithromycin resistance in H. pylori.
Conclusions
The use of macrolide antibiotics and a recent diagnosis of respiratory disease might increase clarithromycin resistance of H. pylori .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
- Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
ORCID-Profile: Sang Pyo Lee
Förderung
- Hallym University Research Fund
Zitieren
APA
Kwon, Y. M., Kim, S. J., Lee, J. G., & Lee, S. P. (2023). Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori. Helicobacter. https://doi.org/10.1111/hel.12974
Vancouver
Kwon YM, Kim SJ, Lee JG, Lee SP. Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori. Helicobacter. 2023. doi:10.1111/hel.12974
BibTeX
@article{Kwon2023,
author = {Kwon, Young-Min and Kim, Sung-Jae and Lee, Jae Gon and Lee, Sang Pyo},
title = {Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori},
journal = {Helicobacter},
year = {2023},
doi = {10.1111/hel.12974}
}
EUVIMED